ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New safety data for leukemia drug BESPONSA in 421 patients
Disease control CompletedThis study looked at the safety and side effects of the drug BESPONSA in 421 adults whose acute lymphocytic leukemia had come back or stopped responding to treatment. All participants received BESPONSA as prescribed by their doctor. The main goal was to track serious side effects…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. The treatment involved taking a patient's own white blood cells, modifying them in a lab to target the CD22 protein on cancer cel…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC